Renal Business Today - Rockwell Medical

Rockwell Names VP of Drug Development, Medical Affairs

WIXOM, Mich.—Rockwell Medical has hired Annamaria T. Kausz, MD, MS, to replace Dr. Richard Yocum as Vice President of Drug Development and Medical Affairs. ...More

September 19, 2011

Posted in News, Business

Rockwell Acquires Generic Vitamin D Drug

WIXOM, Mich.—Rockwell Medical has acquired an abbreviated new drug application (ANDA) for injectable, active Vitamin-D (Calcitriol) for hemodialysis patients. ...More

July 26, 2011

Posted in News, Business, Clinical & Pharma

Rockwell Receives Patent for SFP Packaging, Method of Use

WIXOM, Mich.—The U.S. Patent and Trademark Office has issued a patent to Rockwell Medical for the packaging and method of use for its proprietary iron drug Soluble Ferric Pyrophosphate (SFP). ...More

May 11, 2011

Posted in News, Business, Government & Regulation

Rockwell Begins Second Phase III Clinical Trial for Iron Drug

WIXOM, Mich.—Rockwell Medical announced April 26 that it has initiated enrollment in its second pivotal Phase III clinical study called CRUISE-2, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin. ...More

April 26, 2011

Posted in News, Business, Clinical & Pharma

Rockwell Appoints Crumbliss to Scientific Advisory Board

WIXOM, Mich.—Rockwell Medical has added Alvin L. Crumbliss, PhD, to its scientific advisory board. ...More

April 18, 2011

Posted in News, Business

Rockwell, DaVita Sign Supply Agreement

WIXOM, Mich.—Rockwell Medical and dialysis provider DaVita have signed a supply agreement that will last until 2013, Rockwell announced March 28. ...More

March 28, 2011

Posted in News, Business

Rockwell Starts Phase 3 Enrollment of Iron Study

WIXOM, Mich.—Rockwell Medical has started enrollment in its phase 3 CRUISE-1 clinical study, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin. ...More

March 24, 2011

Posted in News, Clinical & Pharma

LDOs to Participate in Rockwell Iron Drug Studies

WIXOM, Mich.—The clinical research divisions if the two largest dialysis companies have signed agreements to participate in Rockwell Medical’s phase III studies using Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic. ...More

January 26, 2011

Posted in News, Business, Clinical & Pharma

Rockwell's Iron Deficiency Drug Receives Patent

WIXOM, Mich.—The U.S. Patent and Trademark Office has issued a patent to Rockwell Medical for its propriety GMP (good manufacturing process) formulation for its iron drug Soluble Ferric Pyrophosphate (SFP). ...More

October 26, 2010

Posted in News, Business, Government & Regulation

Rockwell to Start SFP Phase III Trials Within 90 Days

WIXOM, Mich.—Rockwell Medical has released the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) and will begin the clinical studies within 90 days, according to a news release. ...More

October 20, 2010

Posted in News, Business, Clinical & Pharma, Government & Regulation

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Rockwell Medical

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail